Brown, Lisle/Cummings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Brown, Lisle/Cummings's LLY Position: Q2 2026 in Review
Brown, Lisle/Cummings reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $46K and leaving 3,308 shares worth $3.97M. The position accounts for 0.89% of the portfolio, ranked #28.
Brown, Lisle/Cummings first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Brown, Lisle/Cummings held 3,308 shares of Eli Lilly worth $3.97M as of Q2 2026.
- Brown, Lisle/Cummings sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
- Eli Lilly made up 0.89% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #28 holding.
- Brown, Lisle/Cummings first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.